Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
- PMID: 31543676
- PMCID: PMC6737313
- DOI: 10.3748/wjg.v25.i33.4814
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
Abstract
The intimate connection and the strict mutual cooperation between the gut and the liver realizes a functional entity called gut-liver axis. The integrity of intestinal barrier is crucial for the maintenance of liver homeostasis. In this mutual relationship, the liver acts as a second firewall towards potentially harmful substances translocated from the gut, and is, in turn, is implicated in the regulation of the barrier. Increasing evidence has highlighted the relevance of increased intestinal permeability and consequent bacterial translocation in the development of liver damage. In particular, in patients with non-alcoholic fatty liver disease recent hypotheses are considering intestinal permeability impairment, diet and gut dysbiosis as the primary pathogenic trigger. In advanced liver disease, intestinal permeability is enhanced by portal hypertension. The clinical consequence is an increased bacterial translocation that further worsens liver damage. Furthermore, this pathogenic mechanism is implicated in most of liver cirrhosis complications, such as spontaneous bacterial peritonitis, hepatorenal syndrome, portal vein thrombosis, hepatic encephalopathy, and hepatocellular carcinoma. After liver transplantation, the decrease in portal pressure should determine beneficial effects on the gut-liver axis, although are incompletely understood data on the modifications of the intestinal permeability and gut microbiota composition are still lacking. How the modulation of the intestinal permeability could prevent the initiation and progression of liver disease is still an uncovered area, which deserves further attention.
Keywords: Bacterial translocation; Cirrhosis; Gut microbiota; Gut-liver axis; Liver disease; Mediterranean diet; Personalized medicine.
Conflict of interest statement
Conflict-of-interest statement: Nothing to declare.
Figures


Similar articles
-
Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26. Hepatol Int. 2018. PMID: 28550391 Free PMC article.
-
Gut-liver axis signaling in portal hypertension.World J Gastroenterol. 2019 Oct 21;25(39):5897-5917. doi: 10.3748/wjg.v25.i39.5897. World J Gastroenterol. 2019. PMID: 31660028 Free PMC article. Review.
-
Potential mechanisms linking gut microbiota and portal hypertension.Liver Int. 2019 Apr;39(4):598-609. doi: 10.1111/liv.13986. Epub 2018 Nov 9. Liver Int. 2019. PMID: 30312513 Review.
-
Liver cirrhosis and complications from the perspective of dysbiosis.Front Med (Lausanne). 2024 Jan 16;10:1320015. doi: 10.3389/fmed.2023.1320015. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38293307 Free PMC article. Review.
-
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD.Sci Rep. 2017 Sep 22;7(1):12200. doi: 10.1038/s41598-017-11744-6. Sci Rep. 2017. PMID: 28939830 Free PMC article.
Cited by
-
Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study.J Clin Exp Hepatol. 2022 Jul-Aug;12(4):1102-1113. doi: 10.1016/j.jceh.2022.01.006. Epub 2022 Jan 24. J Clin Exp Hepatol. 2022. PMID: 35814507 Free PMC article.
-
Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis.World J Clin Cases. 2022 Apr 26;10(12):3662-3676. doi: 10.12998/wjcc.v10.i12.3662. World J Clin Cases. 2022. PMID: 35647163 Free PMC article. Review.
-
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?Int J Gen Med. 2023 Aug 28;16:3889-3906. doi: 10.2147/IJGM.S413438. eCollection 2023. Int J Gen Med. 2023. PMID: 37662503 Free PMC article.
-
Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis.Nutrients. 2020 Feb 21;12(2):564. doi: 10.3390/nu12020564. Nutrients. 2020. PMID: 32098159 Free PMC article.
-
Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.J Gastroenterol Hepatol. 2025 Jan;40(1):33-40. doi: 10.1111/jgh.16750. Epub 2024 Sep 29. J Gastroenterol Hepatol. 2025. PMID: 39343617 Free PMC article. Review.
References
-
- Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809. - PubMed
-
- Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4:478–485. - PubMed
-
- Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. 2014;60:197–209. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical